leuprorelin - leitarniðurstöður

Evrópusambandið - sænska - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostatiska neoplasmer - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

ulimyo 5 mg tablett

aristo pharma gmbh - ulipristalacetat - tablett - 5 mg - ulipristalacetat 5 mg aktiv substans; laktosmonohydrat hjälpämne

Evrópusambandið - sænska - EMA (European Medicines Agency)

orgovyx

accord healthcare s.l.u. - relugolix - prostatiska neoplasmer - endokrin terapi - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Evrópusambandið - sænska - EMA (European Medicines Agency)

erleada

janssen-cilag international nv - apalutamide - prostatiska neoplasmer - endokrin terapi - erleada anges:i vuxna män för behandling av icke metastaserad kastrering resistent prostatacancer (nmcrpc) som är en hög risk att utveckla metastatisk sjukdom. i vuxna män för behandling av metastaserande hormon-känsliga prostatacancer (mhspc) i kombination med androgen fattigdom terapi (adt).

Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)